NCT00004890View on ClinicalTrials.gov

Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

December 31, 2000

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions

Drug ExtravasationKidney Cancer

Interventions

BIOLOGICAL

aldesleukin

DRUG

Biomed 101

Trial Locations (1)

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

BioMedicines

INDUSTRY